Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$82.84 - $88.09 $16,485 - $17,529
-199 Reduced 7.83%
2,344 $204,000
Q4 2023

Jan 26, 2024

SELL
$69.43 - $83.43 $38,394 - $46,136
-553 Reduced 17.86%
2,543 $209,000
Q3 2023

Oct 17, 2023

SELL
$78.22 - $90.4 $369,276 - $426,778
-4,721 Reduced 60.39%
3,096 $242,000
Q2 2023

Jul 18, 2023

SELL
$79.47 - $91.38 $121,906 - $140,176
-1,534 Reduced 16.4%
7,817 $688,000
Q1 2023

Apr 13, 2023

BUY
$76.72 - $87.58 $178,987 - $204,324
2,333 Added 33.24%
9,351 $753,000
Q4 2022

Jan 19, 2023

SELL
$76.18 - $87.74 $147,103 - $169,425
-1,931 Reduced 21.58%
7,018 $0
Q3 2022

Oct 20, 2022

BUY
$80.75 - $95.31 $104,490 - $123,331
1,294 Added 16.9%
8,949 $723,000
Q2 2022

Jul 26, 2022

SELL
$87.4 - $113.09 $1.05 Million - $1.36 Million
-12,034 Reduced 61.12%
7,655 $687,000
Q1 2022

Apr 26, 2022

BUY
$100.58 - $112.38 $977,134 - $1.09 Million
9,715 Added 97.4%
19,689 $2.18 Million
Q4 2021

Jan 24, 2022

BUY
$99.53 - $127.75 $655,106 - $840,850
6,582 Added 194.04%
9,974 $1.03 Million
Q3 2021

Oct 21, 2021

BUY
$122.75 - $135.17 $43,208 - $47,579
352 Added 11.58%
3,392 $425,000
Q2 2021

Jul 14, 2021

BUY
$118.19 - $131.5 $35,929 - $39,976
304 Added 11.11%
3,040 $377,000
Q1 2021

Apr 21, 2021

BUY
$111.18 - $119.74 $18,233 - $19,637
164 Added 6.38%
2,736 $323,000
Q4 2020

Jan 19, 2021

SELL
$100.57 - $117.14 $23,030 - $26,825
-229 Reduced 8.18%
2,572 $301,000
Q3 2020

Oct 16, 2020

BUY
$90.13 - $108.78 $252,454 - $304,692
2,801 New
2,801 $291,000
Q1 2020

Apr 17, 2020

SELL
$72.92 - $121.3 $250,480 - $416,665
-3,435 Closed
0 $0
Q4 2019

Jan 22, 2020

BUY
$104.49 - $114.54 $358,923 - $393,444
3,435 New
3,435 $390,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $115B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track S.E.E.D. Planning Group LLC Portfolio

Follow S.E.E.D. Planning Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of S.E.E.D. Planning Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on S.E.E.D. Planning Group LLC with notifications on news.